TABLE 4.
Dual Stain Triage of HPV-Positive Results When Limited Genotyping Is Provided by the Screening Test in STRIDESa
| Current test result | N | % of Total | CIN3+ cases | CIN3+ immediate risk (%) |
Clinical management recommendation |
|---|---|---|---|---|---|
| DS+/HPV16+ | 178 | 1.8 | 43 | 24.2 | Colposcopy |
| DS−/HPV16+ | 110 | 1.1 | 2 | 1.8 | Special situation |
| DS+/HPV18+ | 72 | 0.7 | 4 | 5.6 | Colposcopy |
| DS−/HPV18+ | 84 | 0.8 | 0 | 0.0 | Special situation |
| DS+/HR12+ | 518 | 5.1 | 41 | 7.9 | Colposcopy |
| DS−/HR12+ | 919 | 9.1 | 4 | 0.5 | 1-y return |
aDuration of follow-up in the STRIDES cohort is currently not sufficient to estimate cumulative 3-year risks and management confidence probabilities; follow-up is ongoing.
STRIDES indicates STudying Risk to Improve DisparitiES in Mississippi.